STING Pathway:

Using a Tumor’s Composition to Activate an Immune Response

Learn More

B-select Antibodies:

Modulating Cancer Immunity 

Learn More

LADD®:

Harnessing the Power of Bacteria to Direct the Immune Response Against Cancer

Learn More

Immunotherapy

Learn how immunotherapies harness a person’s immune system to fight cancer

Learn More

Clinical Trials

Learn more about Aduro’s clinical programs

Learn More

Investors

Download the 2017 Annual Report

Download PDF

Recent News

August 01, 2018 Aduro Biotech Reports Second Quarter 2018 Financial Results

June 07, 2018 Aduro Biotech Announces Initiation of Phase 1b Clinical Trial in Non-Small Cell Lung Cancer under Janssen Strategic Partnership for ADU-214 in Combination with Nivolumab

May 10, 2018 Aduro Biotech to Present at the Bank of America Merrill Lynch 2018 Health Care Conference

Read More

Careers

Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?

Learn More

Media

Learn how Aduro is developing revolutionary new therapies to treat cancers

Learn More